FDA Inspection 1170081 — BOEHRINGER INGELHEIM PROMECO S.A. de C.V.

BOEHRINGER INGELHEIM PROMECO S.A. de C.V. — FEI 1000183111

The FDA completed an inspection of BOEHRINGER INGELHEIM PROMECO S.A. de C.V. on May 20, 2022 in Xochimilco. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 3 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
May 20, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Xochimilco (Mexico)

Citations

IDCFRDescription
109821 CFR 211.22(c)Approve or reject procedures or specs
117721 CFR 211.63Equipment Design, Size and Location
355421 CFR 211.48(a)Potable water standards not met